Filing Details

Accession Number:
0001127602-13-023465
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-25 19:42:19
Reporting Period:
2013-07-23
Filing Date:
2013-07-25
Accepted Time:
2013-07-25 19:42:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100412 Array Biopharma Inc ARRY Pharmaceutical Preparations (2834) 841460811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1191702 R John Moore 3200 Walnut Street
Boulder CO 80301
Vp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-23 5,000 $2.74 16,886 No 4 M Direct
Common Stock Disposition 2013-07-23 5,000 $6.50 11,886 No 4 S Direct
Common Stock Acquisiton 2013-07-25 4,759 $3.75 16,645 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-07-23 5,000 $0.00 5,000 $2.74
Common Stock Stock Option (Right to Buy) Disposition 2013-07-25 4,759 $0.00 4,759 $3.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,000 2020-03-31 No 4 M Direct
0 2013-08-01 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2012.
  2. The option vests in four equal annual installments beginning March 4, 2011.
  3. The option vested in four equal annual installments beginning July 1, 2004.